These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 17717866)

  • 1. Ziprasidone security in overdose: one case report.
    Rodriguez Martinez A; Castaño Asins J
    Actas Esp Psiquiatr; 2007; 35(4):282-3. PubMed ID: 17717866
    [No Abstract]   [Full Text] [Related]  

  • 2. Inadvertent administration of intravenous ziprasidone leading to bradycardia and QT interval prolongation.
    Bentley ML; Biscardi FH; Butcher C; Levitov A
    Ann Pharmacother; 2008 Jun; 42(6):902-3. PubMed ID: 18477728
    [No Abstract]   [Full Text] [Related]  

  • 3. Ziprasidone overdose: cardiac safety.
    Insa Gómez FJ; Gutiérrez Casares JR
    Actas Esp Psiquiatr; 2005; 33(6):398-400. PubMed ID: 16292724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The highest intentional ziprasidone overdose was not fatal.
    Prieto T; Benabarre A; Bernardo M
    Acta Psychiatr Scand; 2005 Jul; 112(1):79-80; author reply 80. PubMed ID: 15952953
    [No Abstract]   [Full Text] [Related]  

  • 5. Third degree heart block following intramuscular ziprasidone.
    Tambyraja R; Strawn JR
    Schizophr Res; 2011 Feb; 125(2-3):302-3. PubMed ID: 20692812
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective observational multi-poison center study of ziprasidone exposures.
    Klein-Schwartz W; Lofton AL; Benson BE; Spiller HA; Crouch BI
    Clin Toxicol (Phila); 2007; 45(7):782-6. PubMed ID: 17926152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-drug overdose risperidone, ziprasidone, valproate, trihexyphenidyl, and clonazepam.
    Rajkumar AP; Jebaraj P; Tharyan P
    J Assoc Physicians India; 2007 Feb; 55():146-8. PubMed ID: 17571746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QT interval--what is normal? Comment on "single-dose ziprasidone associated with QT interval prolongation".
    Sanaei-Zadeh H
    Am J Emerg Med; 2012 May; 30(4):627. PubMed ID: 22306388
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation induced by high-dose ziprasidone: a case report.
    Kaushik S; Maccabee N; Kaushik S; Lindenmayer JP
    J Clin Psychiatry; 2009 Sep; 70(9):1326-7. PubMed ID: 19818257
    [No Abstract]   [Full Text] [Related]  

  • 10. 12,800-mg ziprasidone overdose without significant ECG changes.
    Arbuck DM
    Gen Hosp Psychiatry; 2005; 27(3):222-3. PubMed ID: 15882771
    [No Abstract]   [Full Text] [Related]  

  • 11. No significant QTc interval changes with high-dose ziprasidone: a case series.
    Levy WO; Robichaux-Keene NR; Nunez C
    J Psychiatr Pract; 2004 Jul; 10(4):227-32. PubMed ID: 15552544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric ziprasidone overdose.
    Fasano CJ; O'Malley GF; Lares C; Rowden AK
    Pediatr Emerg Care; 2009 Apr; 25(4):258-9. PubMed ID: 19369840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M; Kuwilsky A; Krumm B; Dressing H
    J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
    Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziprasidone-induced hyperprolactinemia: a case report.
    Citil DY; Selçuk E; Karlidağ R; Unal S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):905-6. PubMed ID: 18276052
    [No Abstract]   [Full Text] [Related]  

  • 16. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article.
    Scott LK; Green R; McCarthy PJ; Conrad SA
    J Neurosurg Pediatr; 2009 Jun; 3(6):484-7. PubMed ID: 19485732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of refractory chronic daily headache with the atypical antipsychotic ziprasidone--a case series.
    Cahill CM; Hardiman O; Murphy KC
    Cephalalgia; 2005 Oct; 25(10):822-6. PubMed ID: 16162260
    [No Abstract]   [Full Text] [Related]  

  • 19. Ziprasidone-associated depressive state in schizophrenic patients.
    Kaptsan A; Dwolatzky T; Lerner V
    Clin Neuropharmacol; 2007; 30(6):357-61. PubMed ID: 18090461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vocal tics associated with ziprasidone.
    Willmund G; Lee AH; Wertenauer F; Laier SA; Lang UE
    J Clin Psychopharmacol; 2009 Dec; 29(6):611-2. PubMed ID: 19910734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.